StockWaves
  • Home
  • Global Markets
    Global MarketsShow More
    This 26-year-old’s blue-collar enterprise brings in .3 million a 12 months
    This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
    9 Min Read
    Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
    Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
    0 Min Read
    3 distinctive funding trusts that would enhance the returns of a Shares and Shares ISA
    3 distinctive funding trusts that would enhance the returns of a Shares and Shares ISA
    4 Min Read
    China shares lag broad Asia rebound,Fed price reduce hopes and Nvidia-Chin
    China shares lag broad Asia rebound,Fed price reduce hopes and Nvidia-Chin
    0 Min Read
    Chinese language corporations chase Africa’s shoppers as useful resource investments plunge 40%
    Chinese language corporations chase Africa’s shoppers as useful resource investments plunge 40%
    9 Min Read
  • Investment Strategies
    Investment StrategiesShow More
    Lloyds Metals & Vitality Ltd – Constructing India’s Subsequent Mining-to-Metals PowerhouseInsights
    Lloyds Metals & Vitality Ltd – Constructing India’s Subsequent Mining-to-Metals PowerhouseInsights
    9 Min Read
    Traders misplaced over 50% good points by lacking the 'finest 3 months'
    Traders misplaced over 50% good points by lacking the 'finest 3 months'
    0 Min Read
    Don't play the ready sport
    Don't play the ready sport
    0 Min Read
    PPFAS plans IPO in 5 years, entry into NPS
    PPFAS plans IPO in 5 years, entry into NPS
    0 Min Read
    Comparable valuations, reverse outcomes
    Comparable valuations, reverse outcomes
    0 Min Read
  • Market Analysis
    Market AnalysisShow More
    Is It Truly Value Rs. 3,000?
    Is It Truly Value Rs. 3,000?
    11 Min Read
    Inventory to purchase briefly time period: Axis Securities recommends this PSU inventory as its ‘Decide of the Week’
    Inventory to purchase briefly time period: Axis Securities recommends this PSU inventory as its ‘Decide of the Week’
    6 Min Read
    YES Financial institution Inventory in Consolidation: A Lengthy-Time period Investor’s Perspective
    YES Financial institution Inventory in Consolidation: A Lengthy-Time period Investor’s Perspective
    10 Min Read
    Nifty, Sensex open flat amid optimism of touching contemporary highs: Consultants
    Nifty, Sensex open flat amid optimism of touching contemporary highs: Consultants
    4 Min Read
    Is that this flexi-cap fund getting too huge to shine
    Is that this flexi-cap fund getting too huge to shine
    0 Min Read
  • Trading
    TradingShow More
    Scott Bessent Says If ‘Radical Left’ Once more Shuts Down Authorities In January, GOP Ought to ‘Instantly Finish’ The Filibuster
    Scott Bessent Says If ‘Radical Left’ Once more Shuts Down Authorities In January, GOP Ought to ‘Instantly Finish’ The Filibuster
    3 Min Read
    Mamdani Says He ‘Continues To Imagine’ Every little thing He’d Mentioned Earlier About Trump Regardless of ‘Very Productive’ Assembly
    Mamdani Says He ‘Continues To Imagine’ Every little thing He’d Mentioned Earlier About Trump Regardless of ‘Very Productive’ Assembly
    3 Min Read
    Scott Bessent Says Individuals Set For ‘Lowest Price’ Thanksgiving Dinner In 4 Years After Being ‘Traumatized’ By Biden-Period Costs
    Scott Bessent Says Individuals Set For ‘Lowest Price’ Thanksgiving Dinner In 4 Years After Being ‘Traumatized’ By Biden-Period Costs
    3 Min Read
    The Insider Report: Put together for the Subsequent Dip Shopping for Alternative – Daqo New Power (NYSE:DQ), Dianthus Therapeutics (NASDAQ:DNTH)
    The Insider Report: Put together for the Subsequent Dip Shopping for Alternative – Daqo New Power (NYSE:DQ), Dianthus Therapeutics (NASDAQ:DNTH)
    21 Min Read
    Elon Musk’s Ex-Spouse Shared Insights Into Their Tumultuous Marriage – Tesla (NASDAQ:TSLA)
    Elon Musk’s Ex-Spouse Shared Insights Into Their Tumultuous Marriage – Tesla (NASDAQ:TSLA)
    3 Min Read
Reading: Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump’s US pharma tariff fears
Share
Font ResizerAa
StockWavesStockWaves
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Search
  • Home
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading
Follow US
2024 © StockWaves.in. All Rights Reserved.
StockWaves > Market Analysis > Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump’s US pharma tariff fears
Market Analysis

Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump’s US pharma tariff fears

StockWaves By StockWaves Last updated: April 9, 2025 5 Min Read
Pfizer, Amgen, Johnson & Johnson, others drop at US market open amid Trump’s US pharma tariff fears
SHARE


Contents
Pharma SharesWall Avenue ImmediatelyTrump Pharma Tariffs

US Markets Immediately: Pharmaceutical sector shares fell at Wall Avenue open on Wednesday, April 9, after worry over the upcoming US tariffs on pharma imports spooked traders amid a raging commerce struggle between the US and different world nations.

Shares like Pfizer, Amgen, Johnson & Johnson, and Eli Lilly & Co. had been amongst others which opened decrease after the US inventory market opened on Wednesday. 

Additionally Learn | Wall Avenue right this moment: S&P 500, Dow Jones, Nasdaq edge larger amid commerce struggle

Pharma Shares

Pfizer Inc. shares are at the moment buying and selling 2.56 per cent decrease at $21.31 as of 10:11 a.m. (EDT), in comparison with $21.84 on the earlier US market shut. The shares opened decrease at $21.11 apiece.

Johnson & Johnson shares are buying and selling 2.37 per cent down at $146.45 after it opened decrease at ₹142.20, in comparison with $150 on the earlier market shut.

Amgen inventory was buying and selling 2.48 per cent decrease at $273.23 within the early market session on the Nasdaq index, in comparison with $280.26 on the earlier shut. The inventory opened decrease at $268.91 on Wall Avenue.

Eli Lilly & Co. shares had been down greater than 3 per cent at $701.25, in comparison with $726.24 on the earlier shut. The inventory was buying and selling decrease than its opening stage of $704.40 on Wednesday’s early market session. 

Additionally Learn | Dow futures tank 2% as China slaps contemporary tariffs on US imports

Merck & Co. Inc. shares additionally dropped over 3 per cent, at the moment buying and selling at $76.61, in comparison with $78.95 on the earlier shut. The multinational pharmaceutical firm’s shares opened decrease at $76.76.

Wall Avenue Immediately

At 9:30 a.m. (EDT), the Dow Jones Industrial Common (DJIA) opened 0.68 per cent decrease at 37,387.91 factors, in comparison with 37,645.59 factors on the earlier inventory market shut.

The Dow was buying and selling 0.14 per cent larger within the early market session on Wall Avenue at 37,708 factors.

The S&P 500 index dropped 0.35 per cent to open at 4,965.28 factors​, in comparison with 4,982.77 factors on the earlier inventory market shut. The index is at the moment buying and selling 0.52 per cent larger on Wall Avenue.

The tech-heavy Nasdaq Composite index gained 0.18 per cent to fifteen,295.441 factors, in comparison with 15,267.91 factors on the earlier market shut. The New York-based index was buying and selling 1.5 per cent larger within the early market session, Marketwatch knowledge reveals. 

Additionally Learn | Dr Reddy’s to Solar Pharma—can Indian drugmakers escape Trump’s tariff tantrums?

Trump Pharma Tariffs

Donald Trump introduced on Tuesday, April 8, that the US will quickly impose a “main” tariff on pharmaceutical imports into the Western nation amid the continued tariff struggle.

“We’re gonna tariff our prescribed drugs … we will be saying very shortly a serious tariff on prescribed drugs,” stated President Donald Trump in his deal with.

Thus far, the prescribed drugs sector has been exempted from the tariffs which had been introduced final week, however now, because the US plans to impose an obligation on drug imports into the nation, traders have develop into cautious in regards to the pharma inventory within the US.

Pharma corporations worldwide depend upon the availability of their uncooked supplies from international nations, and US Massive Pharmaceutical corporations are not any exception.

Examine all US Markets-related information right here

Disclaimer: The views and proposals made above are these of particular person analysts or broking corporations, and never of Mint. We advise traders to examine with licensed consultants earlier than making any funding selections. 

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Previous Article COMTEX | PRESS RELEASE DISTRIBUTION & NEWS API COMTEX | PRESS RELEASE DISTRIBUTION & NEWS API
Next Article Apple bounces 3% after worst shedding streak since 2000 Apple bounces 3% after worst shedding streak since 2000
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow

Subscribe Now

Subscribe to our newsletter to get our newest articles instantly!

Most Popular
This 26-year-old’s blue-collar enterprise brings in .3 million a 12 months
This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
November 24, 2025
Pibit.AI raises M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
Pibit.AI raises $7M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
November 24, 2025
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat
November 24, 2025
Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
Barclays upgrades GN Retailer Nord inventory to Obese on earnings inflection
November 24, 2025
Is It Truly Value Rs. 3,000?
Is It Truly Value Rs. 3,000?
November 24, 2025

You Might Also Like

Are hybrid mutual funds the best alternative for brand new buyers?
Market Analysis

Are hybrid mutual funds the best alternative for brand new buyers?

0 Min Read
Restoration {Hardware} Proprietor Plummets 40% on Trump Tariff Risk
Market Analysis

Restoration {Hardware} Proprietor Plummets 40% on Trump Tariff Risk

3 Min Read
Wall Avenue at this time: US shares surge after courtroom blocks most Trump tariffs, Nvidia climbs 6.4% on sturdy earnings
Market Analysis

Wall Avenue at this time: US shares surge after courtroom blocks most Trump tariffs, Nvidia climbs 6.4% on sturdy earnings

1 Min Read
Fund supervisor adjustments in 5 schemes of SBI Mutual Fund
Market Analysis

Fund supervisor adjustments in 5 schemes of SBI Mutual Fund

0 Min Read

Always Stay Up to Date

Subscribe to our newsletter to get our newest articles instantly!

StockWaves

We provide tips, tricks, and advice for improving websites and doing better search.

Latest News

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms Of Service

Resouce

  • Blockchain
  • Business
  • Economics
  • Financial News
  • Global Markets
  • Investment Strategies
  • Market Analysis
  • Trading

Trending

This 26-year-old’s blue-collar enterprise brings in $1.3 million a 12 months
Pibit.AI raises $7M from Stellaris Enterprise Companions to construct trusted AI for the insurance coverage {industry}
RVNL Wins Rs 181 Crore NE Railway Order; Shares Commerce Flat

2024 © StockWaves.in. All Rights Reserved.

Welcome Back!

Sign in to your account

Not a member? Sign Up